[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Female Contraception Drug Market Report 2017

January 2018 | 98 pages | ID: UC287997F7AEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Female Contraception Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Female Contraception Drug in these regions, from 2012 to 2022 (forecast).
United States Female Contraception Drug market competition by top manufacturers/players, with Female Contraception Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Addex Therapeutics Ltd
  • Agile Therapeutics Inc
  • Bayer AG
  • Evofem Inc
  • Hervana Ltd
  • Mithra Pharmaceuticals SA
  • Orbis Biosciences Inc
  • Teva Pharmaceutical Industries Ltd
  • Viramal Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • AG-890
  • Amphora
  • BAY-1007626
  • Drospirenone
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Homecare
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Female Contraception Drug Market Report 2017

1 FEMALE CONTRACEPTION DRUG OVERVIEW

1.1 Product Overview and Scope of Female Contraception Drug
1.2 Classification of Female Contraception Drug by Product Category
  1.2.1 United States Female Contraception Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Female Contraception Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 AG-890
  1.2.4 Amphora
  1.2.5 BAY-1007626
  1.2.6 Drospirenone
  1.2.7 Others
1.3 United States Female Contraception Drug Market by Application/End Users
  1.3.1 United States Female Contraception Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Homecare
1.4 United States Female Contraception Drug Market by Region
  1.4.1 United States Female Contraception Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Female Contraception Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Female Contraception Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Female Contraception Drug Status and Prospect (2012-2022)
  1.4.5 New England Female Contraception Drug Status and Prospect (2012-2022)
  1.4.6 The South Female Contraception Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Female Contraception Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Female Contraception Drug (2012-2022)
  1.5.1 United States Female Contraception Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Female Contraception Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES FEMALE CONTRACEPTION DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Female Contraception Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Female Contraception Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Female Contraception Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Female Contraception Drug Market Competitive Situation and Trends
  2.4.1 United States Female Contraception Drug Market Concentration Rate
  2.4.2 United States Female Contraception Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Female Contraception Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES FEMALE CONTRACEPTION DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Female Contraception Drug Sales and Market Share by Region (2012-2017)
3.2 United States Female Contraception Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Female Contraception Drug Price by Region (2012-2017)

4 UNITED STATES FEMALE CONTRACEPTION DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Female Contraception Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Female Contraception Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Female Contraception Drug Price by Type (2012-2017)
4.4 United States Female Contraception Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES FEMALE CONTRACEPTION DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Female Contraception Drug Sales and Market Share by Application (2012-2017)
5.2 United States Female Contraception Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES FEMALE CONTRACEPTION DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Addex Therapeutics Ltd
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Female Contraception Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Addex Therapeutics Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Agile Therapeutics Inc
  6.2.2 Female Contraception Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Agile Therapeutics Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bayer AG
  6.3.2 Female Contraception Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer AG Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Evofem Inc
  6.4.2 Female Contraception Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Evofem Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Hervana Ltd
  6.5.2 Female Contraception Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Hervana Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Mithra Pharmaceuticals SA
  6.6.2 Female Contraception Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Orbis Biosciences Inc
  6.7.2 Female Contraception Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Orbis Biosciences Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceutical Industries Ltd
  6.8.2 Female Contraception Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Viramal Ltd
  6.9.2 Female Contraception Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Viramal Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 FEMALE CONTRACEPTION DRUG MANUFACTURING COST ANALYSIS

7.1 Female Contraception Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Female Contraception Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Female Contraception Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Female Contraception Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES FEMALE CONTRACEPTION DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Female Contraception Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Female Contraception Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Female Contraception Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Female Contraception Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Female Contraception Drug
Figure United States Female Contraception Drug Market Size (K Pcs) by Type (2012-2022)
Figure United States Female Contraception Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure AG-890 Product Picture
Figure Amphora Product Picture
Figure BAY-1007626 Product Picture
Figure Drospirenone Product Picture
Figure Others Product Picture
Figure United States Female Contraception Drug Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Female Contraception Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Homecare Examples
Table Key Downstream Customer in Homecare
Figure United States Female Contraception Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Female Contraception Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Female Contraception Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Female Contraception Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Female Contraception Drug Sales Share by Players/Suppliers
Figure 2017 United States Female Contraception Drug Sales Share by Players/Suppliers
Figure United States Female Contraception Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Female Contraception Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Female Contraception Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Female Contraception Drug Revenue Share by Players/Suppliers
Figure 2017 United States Female Contraception Drug Revenue Share by Players/Suppliers
Table United States Market Female Contraception Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Female Contraception Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Female Contraception Drug Market Share of Top 3 Players/Suppliers
Figure United States Female Contraception Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Female Contraception Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Female Contraception Drug Product Category
Table United States Female Contraception Drug Sales (K Pcs) by Region (2012-2017)
Table United States Female Contraception Drug Sales Share by Region (2012-2017)
Figure United States Female Contraception Drug Sales Share by Region (2012-2017)
Figure United States Female Contraception Drug Sales Market Share by Region in 2016
Table United States Female Contraception Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Female Contraception Drug Revenue Share by Region (2012-2017)
Figure United States Female Contraception Drug Revenue Market Share by Region (2012-2017)
Figure United States Female Contraception Drug Revenue Market Share by Region in 2016
Table United States Female Contraception Drug Price (USD/Pcs) by Region (2012-2017)
Table United States Female Contraception Drug Sales (K Pcs) by Type (2012-2017)
Table United States Female Contraception Drug Sales Share by Type (2012-2017)
Figure United States Female Contraception Drug Sales Share by Type (2012-2017)
Figure United States Female Contraception Drug Sales Market Share by Type in 2016
Table United States Female Contraception Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Female Contraception Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Female Contraception Drug by Type (2012-2017)
Figure Revenue Market Share of Female Contraception Drug by Type in 2016
Table United States Female Contraception Drug Price (USD/Pcs) by Types (2012-2017)
Figure United States Female Contraception Drug Sales Growth Rate by Type (2012-2017)
Table United States Female Contraception Drug Sales (K Pcs) by Application (2012-2017)
Table United States Female Contraception Drug Sales Market Share by Application (2012-2017)
Figure United States Female Contraception Drug Sales Market Share by Application (2012-2017)
Figure United States Female Contraception Drug Sales Market Share by Application in 2016
Table United States Female Contraception Drug Sales Growth Rate by Application (2012-2017)
Figure United States Female Contraception Drug Sales Growth Rate by Application (2012-2017)
Table Addex Therapeutics Ltd Basic Information List
Table Addex Therapeutics Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Addex Therapeutics Ltd Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Addex Therapeutics Ltd Female Contraception Drug Sales Market Share in United States (2012-2017)
Figure Addex Therapeutics Ltd Female Contraception Drug Revenue Market Share in United States (2012-2017)
Table Agile Therapeutics Inc Basic Information List
Table Agile Therapeutics Inc Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Agile Therapeutics Inc Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Agile Therapeutics Inc Female Contraception Drug Sales Market Share in United States (2012-2017)
Figure Agile Therapeutics Inc Female Contraception Drug Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Bayer AG Female Contraception Drug Sales Market Share in United States (2012-2017)
Figure Bayer AG Female Contraception Drug Revenue Market Share in United States (2012-2017)
Table Evofem Inc Basic Information List
Table Evofem Inc Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Evofem Inc Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Evofem Inc Female Contraception Drug Sales Market Share in United States (2012-2017)
Figure Evofem Inc Female Contraception Drug Revenue Market Share in United States (2012-2017)
Table Hervana Ltd Basic Information List
Table Hervana Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hervana Ltd Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Hervana Ltd Female Contraception Drug Sales Market Share in United States (2012-2017)
Figure Hervana Ltd Female Contraception Drug Revenue Market Share in United States (2012-2017)
Table Mithra Pharmaceuticals SA Basic Information List
Table Mithra Pharmaceuticals SA Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mithra Pharmaceuticals SA Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Mithra Pharmaceuticals SA Female Contraception Drug Sales Market Share in United States (2012-2017)
Figure Mithra Pharmaceuticals SA Female Contraception Drug Revenue Market Share in United States (2012-2017)
Table Orbis Biosciences Inc Basic Information List
Table Orbis Biosciences Inc Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Orbis Biosciences Inc Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Orbis Biosciences Inc Female Contraception Drug Sales Market Share in United States (2012-2017)
Figure Orbis Biosciences Inc Female Contraception Drug Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Industries Ltd Basic Information List
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Female Contraception Drug Revenue Market Share in United States (2012-2017)
Table Viramal Ltd Basic Information List
Table Viramal Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Viramal Ltd Female Contraception Drug Sales Growth Rate (2012-2017)
Figure Viramal Ltd Female Contraception Drug Sales Market Share in United States (2012-2017)
Figure Viramal Ltd Female Contraception Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Female Contraception Drug
Figure Manufacturing Process Analysis of Female Contraception Drug
Figure Female Contraception Drug Industrial Chain Analysis
Table Raw Materials Sources of Female Contraception Drug Major Players/Suppliers in 2016
Table Major Buyers of Female Contraception Drug
Table Distributors/Traders List
Figure United States Female Contraception Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Female Contraception Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Female Contraception Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Female Contraception Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Female Contraception Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Female Contraception Drug Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Female Contraception Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Female Contraception Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Female Contraception Drug Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Female Contraception Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Female Contraception Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Female Contraception Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Female Contraception Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories